atlasId,atlasName,cohortId,name
668,[JMPark] Famotidine users with COVID-19 hospitalization (analysis 1),668,JMPark_Famotidine_users_with_COVID19_hospitalization_analysis_1
623,"[JMPark] H2RAs users with COVID-19 hospitalization (exclude famotidine, analysis 1)",623,JMPark_H2RAs_users_with_COVID19_hospitalization_exclude_famotidine_analysis_1
621,[JMPark] Occurrence of a composite intensive respiratory intervention during hospitalization,621,JMPark_Occurrence_of_a_composite_intensive_respiratory_intervention_during_hospitalization
595,"[JMPark] PPI drugs users with COVID-19 hospitalization (analysis 2, 3)",595,JMPark_PPI_drugs_users_with_COVID19_hospitalization_analysis_2_3
665,"[JMPark] H2 blocker users with COVID-19 hospitalization (analysis 2, 4)",665,JMPark_H2_blocker_users_with_COVID19_hospitalization_analysis_2_4
672,"[JMPark] non-PPI and non-H2RA users with COVID-19 hospitalization (analysis 3, 4)",672,JMPark_nonPPI_and_nonH2RA_users_with_COVID19_hospitalization_analysis_3_4
